NTRA vs. PFE
Compare and contrast key facts about Natera, Inc. (NTRA) and Pfizer Inc. (PFE).
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: NTRA or PFE.
Correlation
The correlation between NTRA and PFE is 0.40, which is considered to be moderate. This suggests that the two assets have some degree of positive relationship in their price movements. Moderate correlation can be acceptable for portfolio diversification, offering a balance between risk and potential returns.
Performance
NTRA vs. PFE - Performance Comparison
Loading data...
Key characteristics
NTRA:
0.99
PFE:
-0.59
NTRA:
1.96
PFE:
-0.66
NTRA:
1.24
PFE:
0.93
NTRA:
2.35
PFE:
-0.23
NTRA:
6.63
PFE:
-1.00
NTRA:
8.96%
PFE:
13.44%
NTRA:
48.23%
PFE:
24.10%
NTRA:
-77.74%
PFE:
-58.96%
NTRA:
-13.97%
PFE:
-55.70%
Fundamentals
NTRA:
$21.38B
PFE:
$131.28B
NTRA:
-$1.54
PFE:
$1.38
NTRA:
0.00
PFE:
0.59
NTRA:
11.73
PFE:
2.10
NTRA:
17.33
PFE:
1.45
NTRA:
$1.83B
PFE:
$62.46B
NTRA:
$1.13B
PFE:
$42.09B
NTRA:
-$170.27M
PFE:
$16.71B
Returns By Period
In the year-to-date period, NTRA achieves a -3.80% return, which is significantly higher than PFE's -10.70% return.
NTRA
-3.80%
2.86%
12.70%
47.37%
27.67%
N/A
PFE
-10.70%
6.37%
-9.54%
-14.21%
-4.39%
0.69%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
NTRA vs. PFE — Risk-Adjusted Performance Rank
NTRA
PFE
NTRA vs. PFE - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for Natera, Inc. (NTRA) and Pfizer Inc. (PFE). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Loading data...
Dividends
NTRA vs. PFE - Dividend Comparison
NTRA has not paid dividends to shareholders, while PFE's dividend yield for the trailing twelve months is around 7.43%.
| TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
NTRA Natera, Inc. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
PFE Pfizer Inc. | 7.43% | 6.33% | 5.70% | 3.12% | 2.64% | 3.92% | 3.68% | 3.12% | 3.53% | 3.69% | 3.47% | 3.34% |
Drawdowns
NTRA vs. PFE - Drawdown Comparison
The maximum NTRA drawdown since its inception was -77.74%, which is greater than PFE's maximum drawdown of -58.96%. Use the drawdown chart below to compare losses from any high point for NTRA and PFE. For additional features, visit the drawdowns tool.
Loading data...
Volatility
NTRA vs. PFE - Volatility Comparison
Natera, Inc. (NTRA) has a higher volatility of 12.56% compared to Pfizer Inc. (PFE) at 8.64%. This indicates that NTRA's price experiences larger fluctuations and is considered to be riskier than PFE based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading data...
Financials
NTRA vs. PFE - Financials Comparison
This section allows you to compare key financial metrics between Natera, Inc. and Pfizer Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
NTRA vs. PFE - Profitability Comparison
NTRA - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, Natera, Inc. reported a gross profit of 317.22M and revenue of 501.83M. Therefore, the gross margin over that period was 63.2%.
PFE - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, Pfizer Inc. reported a gross profit of 10.87B and revenue of 13.72B. Therefore, the gross margin over that period was 79.3%.
NTRA - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, Natera, Inc. reported an operating income of -79.18M and revenue of 501.83M, resulting in an operating margin of -15.8%.
PFE - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, Pfizer Inc. reported an operating income of 2.79B and revenue of 13.72B, resulting in an operating margin of 20.3%.
NTRA - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, Natera, Inc. reported a net income of -66.94M and revenue of 501.83M, resulting in a net margin of -13.3%.
PFE - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, Pfizer Inc. reported a net income of 2.97B and revenue of 13.72B, resulting in a net margin of 21.6%.